G. Pignot

5.1k total citations · 1 hit paper
168 papers, 2.6k citations indexed

About

G. Pignot is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, G. Pignot has authored 168 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Surgery, 63 papers in Pulmonary and Respiratory Medicine and 34 papers in Urology. Recurrent topics in G. Pignot's work include Bladder and Urothelial Cancer Treatments (100 papers), Urinary and Genital Oncology Studies (65 papers) and Renal cell carcinoma treatment (33 papers). G. Pignot is often cited by papers focused on Bladder and Urothelial Cancer Treatments (100 papers), Urinary and Genital Oncology Studies (65 papers) and Renal cell carcinoma treatment (33 papers). G. Pignot collaborates with scholars based in France, Italy and United States. G. Pignot's co-authors include Marc Zerbib, Morgan Rouprêt, Delphine Amsellem‐Ouazana, B Debré, Annick Vieillefond, Y. Neuzillet, T Flam, Pierre Colin, S Conquy and Ivan Bièche and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Scientific Reports.

In The Last Decade

G. Pignot

146 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update

2025 18 citations Laurence Albigès, G. Pignot et al. European Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Pignot France	26	1.4k	992	773	535	461	168	2.6k
Matthew Kaag United States	26	1.7k 1.2×	1.1k 1.1×	640 0.8×	468 0.9×	207 0.4×	74	2.6k
A. Masson-Lecomte France	18	1.7k 1.2×	665 0.7×	463 0.6×	462 0.9×	154 0.3×	87	2.2k
Atreya Dash United States	27	1.1k 0.7×	1.3k 1.3×	618 0.8×	581 1.1×	242 0.5×	85	2.6k
Jacques Irani France	30	1.1k 0.8×	1.5k 1.5×	490 0.6×	428 0.8×	337 0.7×	166	2.8k
Jinsoo Chung South Korea	23	634 0.4×	979 1.0×	493 0.6×	449 0.8×	325 0.7×	143	1.7k
Anna Orsola Spain	26	1.3k 0.9×	802 0.8×	359 0.5×	645 1.2×	166 0.4×	64	2.2k
Thomas L. Jang United States	22	637 0.4×	1.4k 1.4×	979 1.3×	579 1.1×	221 0.5×	120	2.5k
Laurent Zini France	26	781 0.5×	1.1k 1.1×	783 1.0×	175 0.3×	274 0.6×	47	1.7k
Francesco Soria Italy	25	2.0k 1.4×	556 0.6×	314 0.4×	590 1.1×	162 0.4×	139	2.6k
Rodolphe Thuret France	27	1.0k 0.7×	1.3k 1.3×	479 0.6×	458 0.9×	180 0.4×	109	2.2k

Countries citing papers authored by G. Pignot

Since Specialization

Citations

This map shows the geographic impact of G. Pignot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Pignot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Pignot more than expected).

Fields of papers citing papers by G. Pignot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Pignot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Pignot. The network helps show where G. Pignot may publish in the future.

Co-authorship network of co-authors of G. Pignot

This figure shows the co-authorship network connecting the top 25 collaborators of G. Pignot. A scholar is included among the top collaborators of G. Pignot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Pignot. G. Pignot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fléchon, Aude, G. Pignot, J. Rigaud, et al.. (2025). Primary urethral cancer: Treatment patterns, responses and survival in localized, advanced and metastatic patients. BJUI Compass. 6(7). e70056–e70056.

Bertaut, Aurélie, G. Pignot, Nadine Houédé, et al.. (2025). LBA107 ALBAN: A phase III, randomized, open-label, international study of intravenous (iv) atezolizumab and intravesical Bacillus Calmette-Guérin (BCG) vs BCG alone in BCG-naïve high-risk, non-muscle-invasive bladder cancer (NMIBC). Annals of Oncology. 36. S1649–S1650.

Daneshmand, Siamak, Renata Zaucha, James W.F. Catto, et al.. (2025). Erdafitinib in Patients with High- and Intermediate-risk Non–muscle-invasive Bladder Cancer: Final Analysis of THOR-2 Study. European Urology. 89(2). 165–173.

Daneshmand, Siamak, Renata Zaucha, Nikhil Vasdev, et al.. (2024). MARKER LESION STUDY OF ORAL ERDAFITINIB IN PATIENTS WITH INTERMEDIATE-RISK NON-MUSCLE–INVASIVE BLADDER CANCER WITH FGFR3/2 ALTERATIONS IN THOR-2: UPDATED COHORT 3 RESULTS. Urologic Oncology Seminars and Original Investigations. 42. S58–S58. 1 indexed citations

Albigès, Laurence, G. Pignot, Gwénaëlle Gravis, et al.. (2024). Delayed partial nephrectomy following complete response to immunotherapy: feasibility and results (UroCCR n°157). Urologic Oncology Seminars and Original Investigations. 43(5). 332.e19–332.e26.

Vaccaro, Chiara, et al.. (2024). Fully sexual‐sparing robot‐assisted cystectomy: a step‐by‐step surgical technique. British Journal of Urology. 134(3). 501–503. 1 indexed citations

Lebrét, Thierry, G. Pignot, M. Roumiguié, et al.. (2023). L’intelligence artificielle pour améliorer les performances de la cytologie dans le diagnostic du carcinome urothélial de la vessie résultats de l’étude prospective française multicentrique VISIOCYT1. 33(3). S76–S76. 1 indexed citations

Pignot, G., Michaël Baboudjian, C. Lebâcle, et al.. (2023). Efficacy of hyperthermic intravesical chemotherapy (HIVEC) in patients with non-muscle invasive bladder cancer after BCG failure. World Journal of Urology. 41(11). 3195–3203. 10 indexed citations

Bigot, Pierre, Alexandre Ingels, Morgan Rouprêt, et al.. (2023). Clinical trial protocol for P-NeLoP: a randomized controlled trial comparing the feasibility and outcomes of robot-assisted partial nephrectomy with low insufflation pressure using AirSeal versus standard insufflation pressure (UroCCR no. 85 study). Trials. 24(1). 545–545. 1 indexed citations

10.

Lorusso, Vito, G. Pignot, Nicolas Branger, et al.. (2022). External validation of the computerized analysis of TRUS of the prostate with the ANNA/C-TRUS system: a potential role of artificial intelligence for improving prostate cancer detection. World Journal of Urology. 41(3). 619–625. 7 indexed citations

11.

Roumiguié, M., Éva Compérat, Léonor Chaltiel, et al.. (2020). PD-L1 expression and pattern of immune cells in pre-treatment specimens are associated with disease-free survival for HR-NMIBC undergoing BCG treatment. World Journal of Urology. 39(11). 4055–4065. 16 indexed citations

12.

Régnier, P., Serge Brunelle, Jochen Walz, et al.. (2020). Impact of sarcopenia status of muscle-invasive bladder cancer patients on kidney function after neoadjuvant chemotherapy and post cystectomy complications.. Minerva Urologica e Nefrologica. 4 indexed citations

13.

Pignot, G. & Paul Sargos. (2020). Place de la radiothérapie adjuvante après cystectomie pour les tumeurs de vessie infiltrant le muscle. Progrès en Urologie. 31(3). 158–168. 1 indexed citations

14.

Lannes, F., Nicolas Branger, Sophie Giusiano, et al.. (2019). Extent of positive surgical margins following radical prostatectomy: impact on biochemical recurrence with long-term follow-up. BMC Urology. 19(1). 37–37. 24 indexed citations

15.

Garinet, Simon, G. Pignot, Sophie Vacher, et al.. (2018). High Prevalence of a Hotspot of Noncoding Somatic Mutations in Intron 6 of GPR126 in Bladder Cancer. Molecular Cancer Research. 17(2). 469–475. 18 indexed citations

16.

Pignot, G., Nadine Houédé, M. Roumiguié, et al.. (2018). Pièce opératoire ypT0N0 après séquence chimiothérapie néo-adjuvante – cystectomie pour TVIM : épidémiologie et impact pronostique. Une mise au point du CCAFU Vessie. Progrès en Urologie. 28(12). 567–574. 5 indexed citations

17.

Loriot, Yohann, S. Supiot, Jean‐Baptiste Beauval, et al.. (2018). Management of non-metastatic castrate-resistant prostate cancer: A systematic review. Cancer Treatment Reviews. 70. 223–231. 17 indexed citations

18.

Neuzillet, Y., Pierre Colin, Éva Compérat, et al.. (2016). Enquête observationnelle du Comité de cancérologie de l’association française d’urologie (CCAFU) sur la pratique des instillations postopératoires précoces (IPOP) de mitomycine C pour le traitement des tumeurs de vessie n’infiltrant pas le muscle (TVNIM). Progrès en Urologie. 26(3). 181–190. 2 indexed citations

19.

Pignot, G., et al.. (2014). Surgical management of locally advanced and metastatic renal cancer: neoadjuvant and adjuvant strategies.. PubMed. 66(1). 49–55. 1 indexed citations

20.

Ouzaïd, Idir, Évanguelos Xylinas, G. Pignot, et al.. (2012). Laparoscopic Partial Nephrectomy: Is It Worth Still Performing the Retroperitoneal Route?. Advances in Urology. 2012. 1–5. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact